Available now in Alchimiaweb, Nightingale, developed by Medical Marijuana Genetics, is a hybrid between Shiskaberry and their Candida with 10-20% CBD content.
There are basically two phenotypes of Nightingale: one closer to Candida, more Sativa and with 1:1 THC:CBD ratio, and another one more Indica which, according to the studies conducted by MMG, can reach 1:20 THC:CBD ratio, up to 20% cannabidiol.
The flowering period lasts around 8-9 weeks, giving yields of between 300 - 500g of solid, frosty buds per m2.
According to MMG, this strain is suitable to treat chronic pain, nausea, vomiting, insomnia and also multiple sclerosis.
For a wide range of CBD-related products intended for therapeutic use, have a look in our online CBD Store.
Medical Marijuana Genetics Nightingale info:
- Sex: Feminised
- Genetics: Shiskaberry x Candida
- THC:CBD ratio: from 1:1 to 1:20
- THC: 0.68 - 9%
- CBD: 10.3 - 20.3%
- Yield: 300-500g per m2
- Indoor flowering: 8-9 weeks